What is the optimal duration of oral misoprostol treatment for cervical ripening?

References

• Walt RP. Misoprostol for the treatment of peptic ulcer and antiinflammatory-drug-induced gastroduodenal ulceration. N Engl J Med 1992;327:1575–80
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin number 67: medical management of abortion. Obstet Gynecol 2005;106:871–81
   PubMedGoogle Scholar
• Lalonde A, Daviss BA, Acosta A, Herschderfer K. Postpartum hemorrhage today: ICM/FIGO initiative 2004–2006. Int J Gynaecol Obstet 2006;94:243–53
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Gulmezoglu AM, Alfirevic Z. Misoprostol for induction of labour: a systematic review. Br J Obstet Gynaecol 1999;106:798–803
   PubMedGoogle Scholar
• ACOG practice bulletin no. 107: induction of labor. Obstet Gynecol 2009;114:386–97
   PubMedGoogle Scholar
• Krause E, Malorgio S, Kuhn A, et al. Off-label use of misoprostol for labor induction: a nation-wide survey in Switzerland. Eur J Obstet Gynecol Reprod Biol 2011;159:324–8
   PubMed Web of Science ®Google Scholar
• Faucett AM, Daniels K, Lee HC, et al. Oral misoprostol versus vaginal dinoprostone for labor induction in nulliparous women at term. J Perinatol 2014;34:95–9
   PubMed Web of Science ®Google Scholar
• Swissmedic, Official Swiss agency for therapeutic products [Internet]. Available from: http://www.swissmedicinfo.ch[last accessed 31 Dec 2015]
   Google Scholar
• Alfirevic Z. Oral misoprostol for induction of labour. Cochrane Database Syst Rev 2001;CD001338
   PubMed Web of Science ®Google Scholar
• Alfirevic Z, Aflaifel N, Weeks A. Oral misoprostol for induction of labour. Cochrane Database Syst Rev 2014;(6):CD001338. doi: 10.1002/14651858.CD001338.pub3
   Google Scholar
• Alfirevic Z, Keeney E, Dowswell T, et al. Labour induction with prostaglandins: a systematic review and network meta-analysis. BMJ 2015;350:h217. doi: 10.1136/bmj.h217
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Gulmezoglu AM, Pileggi C. Vaginal misoprostol for cervical ripening and induction of labor. Cochrane Database Syst Rev 2010;(10):CD000941. doi: 10.1002/14651858.CD000941.pub2
   PubMed Web of Science ®Google Scholar
• Weeks A, Alfirevic Z, Faundes A, et al. Misoprostol for induction of labor with a live fetus. Int J Gynaecol Obstet 2007;99:S194–7
   Google Scholar
• Allen R, O’Brien BM. Uses of misoprostol in obstetrics and gynecology. Rev Obstet Gynecol 2009;2:159–68
   PubMedGoogle Scholar
• Colon I, Clawson K, Hunter K, et al. Prospective randomized clinical trial of inpatient cervical ripening with stepwise oral misoprostol vs vaginal misoprostol. Am J Obstet Gynecol 2005;192:747–52
   PubMed Web of Science ®Google Scholar
• Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17:332–6
   PubMed Web of Science ®Google Scholar
• Kwon JS, Davies GA, Mackenzie VP. A comparison of oral and vaginal misoprostol for induction of labour at term: a randomised trial. BJOG 2001;108:23–6
   PubMed Web of Science ®Google Scholar
• Dodd JM, Crowther CA, Robinson JS. Oral misoprostol for induction of labour at term: randomised controlled trial. BMJ 2006;332:509–13
   PubMed Web of Science ®Google Scholar
• Dallenbach P, Boulvain M, Viardot C, Irion O. Oral misoprostol or vaginal dinoprostone for labor induction: a randomized controlled trial. Am J Obstet Gynecol 2003;188:162–7
   PubMed Web of Science ®Google Scholar
• How HY, Leaseburge L, Khoury JC, et al. A comparison of various routes and dosages of misoprostol for cervical ripening and the induction of labor. Am J Obstet Gynecol 2001;185:911–15
   PubMed Web of Science ®Google Scholar
• Majoko F, Zwizwai M, Nyström L, Lindmark G. Vaginal misoprostol for induction of labour: a more effective agent than prostaglandin F2α gel and prostaglandin E2 pessary. Central Afr J Med 2002;48:123–8
   PubMedGoogle Scholar
• Shetty A, Danielian P, Templeton A. A comparison of oral and vaginal misoprostol tablets in induction of labour at term. BJOG 2001;108:238–43
   PubMed Web of Science ®Google Scholar
• Shetty A, Martin R, Danielian P, Templeton A. A comparison of two dosage regimens of oral misoprostol for labor induction at term. Acta Obstet Gynecol Scand 2002;81:337–42
   PubMed Web of Science ®Google Scholar
• Pongsatha S, Sirisukkasem S, Tongsong T. A comparison of 100 μg oral misoprostol every 3 hours and 6 hours for labor induction: a randomized controlled trial. J Obstet Gynaecol Res 2002;28:308–12
   PubMed Web of Science ®Google Scholar
• Thaisomboon A, Russameecharoen K, Wanitpongpan P, et al. Comparison of the efficacy and safety of titrated oral misoprostol and a conventional oral regimen for cervical ripening and labor induction. Int J Gynaecol Obstet 2012;116:13–16
   PubMed Web of Science ®Google Scholar
• Ngai SW, To WK, Lao T, Ho PC. Cervical priming with oral misoprostol in pre-labor rupture of membranes at term. Obstet Gynecol 1996;87:923–6
   PubMed Web of Science ®Google Scholar
• Dannenbring D, Stevens MJ, House AE. Predictors of childbirth pain and maternal satisfaction. J Behav Med 1997;20:127–42
   PubMed Web of Science ®Google Scholar
• Bishop EH. Pelvic scoring for elective induction. Obstet Gynecol 1964;24:266–8
   PubMed Web of Science ®Google Scholar
• Centre for Women’s and Children’s Health (UK). NICE Clinical Guidelines, No. 55. Intrapartum care: care of healthy women and their babies during childbirth. London: RCOG Press; 2007
   Google Scholar
• Fine JPGR. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999;94:496–509
   Web of Science ®Google Scholar
• Tang J, Kapp N, Dragoman M, de Souza JP. WHO recommendations for misoprostol use for obstetric and gynecologic indications. Int J Gynaecol Obstet 2013;121:186–9
   PubMed Web of Science ®Google Scholar
• Cheung PC, Yeo EL, Wong KS, Tang LC. Oral misoprostol for induction of labor in prelabor rupture of membranes (PROM) at term: a randomized control trial. Acta Obstet Gynecol Scand 2006;85:1128–33
   PubMed Web of Science ®Google Scholar
• Nagpal MB, Raghunandan C, Saili A. Oral misoprostol versus intracervical prostaglandin E2 gel for active management of premature rupture of membranes at term. Int J Gynecol Obstet 2009;106:23–6
   PubMed Web of Science ®Google Scholar
• Mehrabadi A, Hutcheon J, Lee L, et al. Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: a population‐based retrospective cohort study. BJOG 2013;120:853–62
   PubMed Web of Science ®Google Scholar